MedPath

Factors Predicting Erythropoietin Responsiveness in Children on Hemodialysis at Sohag University Hospital

Conditions
Pediatric Patients on Hemodialysis
Interventions
Diagnostic Test: seum zinic,vit B12, parathyriod function
Registration Number
NCT05312346
Lead Sponsor
Sohag University
Brief Summary

Anemia is common in patients on hemodialysis (HD) due to lack of erythropoietin (EPO) synthesis and iron deficiency is occurring in HD patients due to chronic blood loss through the dialysis circuit, repeated blood sampling, shortened red blood cell life span and lack of adherence to treatment .

Anemia is one of the most important complications that affects morbidity and mortality in chronic kidney disease (CKD) patients. It has significant impacts on those patients such as fatigue, weakness, shortness of breath, decreased quality of life, exercise capacity and physical activity, growth retardation and decreased cognitive functions, left ventricular hypertrophy, and congestive heart failure So, proper management of anemia is very important .

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • (1) patients started dialysis in the age range of 1-18years. (2) Patient will be on regular hemodialysis.
Exclusion Criteria
  • Children who have no other co existent hematological disorder .

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
responsiveness to erythropoietin stimulating agentseum zinic,vit B12, parathyriod functionwe evolute responsiveness of patients on hemodialysis for erythropoietin stimulating agents or not and factors effecting this response
Primary Outcome Measures
NameTimeMethod
Serum creatinineone year

serum creatinine

Hb g/dlone year

measure hemoglobin level

Iron profileone year

measure iron profile on blood

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University Hospital

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath